Abstract
Occupational asthma (OA) has emerged as the commonest occupational lung disease in developed countries and the second commonest in developing countries. Nearly 9-15% of the global adult asthma is occupation associated. However, this is an underestimation as large proportion of occupational asthma remains unidentified in developing world. The economic burden of OA is enormous but the disease is potentially preventable. The western models of documenting and legislation implementation models have provided a scaffold to curb various occupation morbidities of the world. Many government and non-government bodies along pertinent political inclination have been instrumental in the risk factor identification and sensitizer dose assessment for OA in the developed countries, and also ensuring that patients are adequately treated and compensated by the employers, with execution of good ergonomic practices in work places. The characteristic of OA epidemiology in developing world is contrary to the poor diagnosis, inappropriate treatment and inadequate compensation, with lack of political will. This mandates necessity of learning from developed country occupational disease models context to understanding of OA, along with reliable and feasible diagnostics and interventions that will have the potential to minimize the health hazards from the exposures at workplace environments in developing countries.
Keywords: Occupational asthma, developing countries, work-aggravated asthma.
Current Respiratory Medicine Reviews
Title:Occupational Exposure and Occupational Asthma: Difference in Practices in Developed Countries v/s Developing Countries
Volume: 12 Issue: 1
Author(s): Bill Brashier
Affiliation:
Keywords: Occupational asthma, developing countries, work-aggravated asthma.
Abstract: Occupational asthma (OA) has emerged as the commonest occupational lung disease in developed countries and the second commonest in developing countries. Nearly 9-15% of the global adult asthma is occupation associated. However, this is an underestimation as large proportion of occupational asthma remains unidentified in developing world. The economic burden of OA is enormous but the disease is potentially preventable. The western models of documenting and legislation implementation models have provided a scaffold to curb various occupation morbidities of the world. Many government and non-government bodies along pertinent political inclination have been instrumental in the risk factor identification and sensitizer dose assessment for OA in the developed countries, and also ensuring that patients are adequately treated and compensated by the employers, with execution of good ergonomic practices in work places. The characteristic of OA epidemiology in developing world is contrary to the poor diagnosis, inappropriate treatment and inadequate compensation, with lack of political will. This mandates necessity of learning from developed country occupational disease models context to understanding of OA, along with reliable and feasible diagnostics and interventions that will have the potential to minimize the health hazards from the exposures at workplace environments in developing countries.
Export Options
About this article
Cite this article as:
Brashier Bill, Occupational Exposure and Occupational Asthma: Difference in Practices in Developed Countries v/s Developing Countries, Current Respiratory Medicine Reviews 2016; 12 (1) . https://dx.doi.org/10.2174/1573398X11666151028205538
DOI https://dx.doi.org/10.2174/1573398X11666151028205538 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anti-inflammatory and Hypolipidemic Effect of Novel Conjugates with Trolox and Other Antioxidant Acids
Medicinal Chemistry Cellular Players in Lung Fibrosis
Current Pharmaceutical Design A Systems Medicine Clinical Platform for Understanding and Managing Non- Communicable Diseases
Current Pharmaceutical Design Chemical Constituents and Biological Activities of Cordia myxa L.: A Review
The Natural Products Journal Activities of Venom Proteins and Peptides with Possible Therapeutic Applications from Bees and WASPS
Protein & Peptide Letters Editorial on the Occasion of the 20th Anniversary of Endocrine Metabolic Immune Disorders-Drug Targets Journal with a Kaleidoscopic Vision of Selected Publications
Endocrine, Metabolic & Immune Disorders - Drug Targets A Review of the English and Russian Language Literature on the Osteoarticular Manifestations of Brucellosis Infection
Current Rheumatology Reviews Patent Selections
Recent Patents on Drug Delivery & Formulation SARS-CoV-2 & Covid-19: Key-Roles of the ‘Renin-Angiotensin’ System / Vitamin D Impacting Drug and Vaccine Developments
Infectious Disorders - Drug Targets A New Era of Pulmonary Delivery of Nano-antimicrobial Therapeutics to Treat Chronic Pulmonary Infections
Current Pharmaceutical Design Advances in Anti-inflammatory Activity, Mechanism and Therapeutic Application of Ursolic Acid
Mini-Reviews in Medicinal Chemistry Natural Anti-inflammatory Compounds as Drug Candidates in Alzheimer’s Disease
Current Medicinal Chemistry The Promise of Plant-Derived Substances as Inhibitors of Arginase
Mini-Reviews in Medicinal Chemistry Adrenergic Action in Breast Cancer
Current Cancer Therapy Reviews Targeting Allergic Airway Diseases by siRNA: An Option for the Future?
Current Molecular Medicine T Cell Homeostasis in Centenarians: From the Thymus to the Periphery
Current Pharmaceutical Design Chemical Biology: Past, Present and Future
Current Chemical Biology Design and Optimization of a Chronotherapeutic Dosage Form for Treatment of Nocturnal Acid Breakthrough
Current Drug Delivery Pyrrolo[2,3-d]Pyrimidines as Kinase Inhibitors
Current Medicinal Chemistry An Update on the Roles of the Complement System in Autoimmune Diseases and the Therapeutic Possibilities of Anti-Complement Agents
Current Drug Therapy